郑州微飒生物科技有限责任公司 咨询热线:0371-88821766
行业动态

行业动态

追踪行业前沿,洞察产业趋势

药效评价Ranking of multidimensional drug profiling data by fractional-adjusted bi-partitional scores.

期刊:Bioinformatics (Oxford, England)发表年份:2012作者:Dorit S Hochbaum; Chun-Nan Hsu; Yan T Yang

药效评价N-substituted phenoxazine and acridone derivatives: structure-activity relationships of potent P2X4 receptor antagonists.

期刊:Journal of medicinal chemistry发表年份:2012作者:Victor Hernandez-Olmos; Aliaa Abdelrahman; Ali El-Tayeb; Diana Freudendahl; Stephanie Weinhausen; Christa E Müller

药效评价Spatial proximity between the VPAC1 receptor and the amino terminus of agonist and antagonist peptides reveals distinct sites of interaction.

期刊:FASEB journal : official publication of the Federation of American Societies for Experimental Biology发表年份:2012作者:Emilie Ceraudo; Régine Hierso; Yossan-Var Tan; Samuel Murail; Christiane Rouyer-Fessard; Pascal Nicole; Jean-Claude Robert; Nadège Jamin; Jean-Michel Neumann; Patrick Robberecht; Marc Laburthe; Alain Couvineau

药效评价Synthesis and pharmacological evaluation of dual acting antioxidant A(2A) adenosine receptor agonists.

期刊:Journal of medicinal chemistry发表年份:2012作者:Nicholas E Hausler; Shane M Devine; Fiona M McRobb; Lyndon Warfe; Colin W Pouton; John M Haynes; Steven E Bottle; Paul J White; Peter J Scammells